INCHEON, Korea, April 23, 2026–Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced its financial results for the first quarter of fiscal year 2026.
This post was originally published on this site.
Leave a Reply